Objective: To determine HIV seroincidence, study participant retention rate, and baseline predictors of HIV incidence and study retention among high-risk injection drug users (IDUs) in Xinjiang, China. Methods: A total of 508 eligible seronegative high-risk IDUs were enrolled. Study participants were tested for HIV-1 and counseled at the baseline, 6-month, and 12-month follow-up visits. Sociodemographic and behavioral data were collected during each study visit. The HIV-1 incidence rate and the retention rate were analyzed as a function of sociodemographic, behavioral, and recruitment variables. Results: At 12 months of follow-up, the HIV-1 incidence rate was 8.8 per 100 person-years (95% CI 6.3-12.0%) and the participant retention rate was 93%.
Introduction
The Chinese Ministry of Health (MOH) estimates that the number of people currently living with HIV/AIDS in China is 650 000, corresponding to a prevalence rate of 0.05% at the end of 2005. 1 The MOH also estimated that injection drug user (IDU)-related transmission accounted for 44.3% of HIV infections, followed by heterosexual transmission (19.6%), former commercial blood and plasma donations (10.7%), and men who have sex with men (7.3%). 1 While HIV prevalence in China has not reached the levels seen in some other areas of the world, high-risk behaviors associated with HIV, such as needle sharing and unprotected sexual intercourse, are on the rise. 1 Heroin abuse first emerged as a problem in China's border region with Myanmar in Yunnan province in the late 1980s. 2, 3 The first HIV outbreak among injection drug users (IDUs) in China was reported in Yunnan in 1989. 4 By the end of 2002, all 31 of China's provinces, municipalities, and autonomous regions reported HIV infection among the population. 1 The reported number of drug users in China in 2003 was 1.0 million, with an annual increase rate of 11% increase in the past four years. 5 Sharing needles and syringes are the predominant mode of HIV transmission, with IDUs accounting for 71% of all HIV/AIDS reported cases in China. 6 Although HIV seroprevalence among the general Chinese population is still relatively low, evidence shows that the epidemic is spreading from high-risk populations such as IDUs and commercial sex workers (CSWs) to the general population due to unprotected sexual intercourse. 1 In a country that contains more than 20% of the world's population, the potential exists for millions of people to become HIV infected, despite a relatively low HIV seroprevalence rate.
The first case of HIV infection was not identified in Xinjiang Uighur Autonomous Region until 1995. [7] [8] [9] However, Xinjiang had the second highest number of reported cases of HIV/AIDS in China with the exception of Yunnan by the end of 2002. 8 Ten years into the HIV epidemic in China, HIV seroprevalence among IDUs in some areas of Xinjiang has risen to 80%. 1 According to the Xinjiang HIV surveillance data, drug-related HIV transmission accounted for 75.5% of infections detected in 2003 with other modes of HIV transmission on the increase. 8 However, very few studies have been conducted in China to estimate HIV seroconversion incidence and study retention rates among IDUs. The HIV Prevention Trials Network (HPTN) Preparedness Study, HPTN 033, was a prospective cohort study in Urumqi, Xinjiang to observe HIV seroincidence, the study retention rate, and determine baseline predictors of HIV incidence and study retention.
Methods
Inclusion criteria for subjects of the HPTN 033 study were the following: (1) HIV-1 antibody negative at enrollment; (2) injected drugs at least three times per week in the previous month or on at least three occasions in the previous three months used injection equipment after another person; (3) expressed a willingness to continue to participate for twelve months; and (4) were able and willing to provide written informed consent and sufficient locator information. Potential participants who had an obvious psychological/psychiatric disorder or any other condition that, in the opinion of the investigator, would preclude provision of informed consent, make participation in the study unsafe, or otherwise interfere with achieving the study objectives were excluded from the study. Initially, males and females had to be 18 years old or older to be eligible, but this requirement was amended near the end of the recruitment period in order to include 16and 17-year-old IDUs in the cohort.
The Xinjiang Uighur Autonomous Regional Institutional Review Board (IRB) and the Western IRB in Olympia, Washington, USA, approved the study protocol before it started in July 2002. All participants gave written informed consent prior to enrollment.
Participant recruitment and retention
From July to December 2002 potential study subjects were recruited by means of target sampling. Outreach workers were recruited from the neighborhoods in and surrounding Urumqi that were known to have high concentrations of IDUs. Staff from the Urumqi Detoxification Center informed drug users after their release that they could refer other drug users or potentially enroll themselves into our study if they had not been in the Detoxification Center within at least the last month. Staff from the Urumqi Detoxification Center referred recent releases. Study subjects were allowed to refer a maximum of five peers. For each peer that was referred and successfully enrolled into the study, a study participant was given a small monetary incentive (US $2.50).
One of the important objectives of the study was to estimate the retention rate of high-risk IDUs in a standardized HIV-related research study. A high retention rate in longitudinal studies plays a crucial role in preventing potential biases due to missing data. Preparation for follow-up visits began with obtaining sufficient locator information from a participant at the enrollment visit. Each participant was required to provide at least two different contact sources (including different addresses or telephone numbers for the participant or his/her family members and friends) to qualify for this study. After a participant was enrolled, the data manager entered the locator information into the Participant Information File System (PIFS) software program. Whenever possible, the follow-up visits were scheduled on the 'target date'. Appointment reminder procedures at follow-up every 6 months included: (1) study staff sent a reminder letter or made a telephone call to remind the participant 2-3 weeks before the scheduled Conclusions: HIV incidence is high among IDUs in Xinjiang, China. Baseline predictors of incidence and retention were minimal. The participant retention rate in this study is promising for the undertaking of future HIV intervention studies. # 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Outreach workers also checked drug detoxification centers and prison systems to determine the reason for a missed visit or a loss to follow-up. Access to the PIFS was strictly protected through a database security system. Prior to the initiation of the study we informed the local public security officials about the study. They were supportive of the study and agreed not to target or interfere with participants. In addition, all study staff at the clinic received Good Clinical Practice (GCP) training and then signed a confidentiality agreement. Outreach workers were also trained not to disclose any study-related information to other persons whom they contacted in the process of finding study participants in the community. A private counseling room was used in interviews and study files containing personal identifiers were kept in a locked room with access limited to study personnel.
Data collection
Screening and enrollment procedures included several steps. The prescreening interviews occurred during the recruitment of IDUs in the field, to establish if there was interest in participation, to communicate the location of the research site, and to determine if transportation assistance was needed. Screening at the study site confirmed eligibility and consent was obtained to perform HIV-1 testing by enzyme immunoassay (Vironostica HIV-Uni-Form II plus 0, BioMerieux, The Netherlands) with confirmatory Western Blot (Gene Labs Diagnostics, Singapore). A risk assessment questionnaire was also administered at screening, which focused on drug-and sex-related behavioral risk factors. The questionnaire was designed to collect self-reported sociodemographic data and behavioral information concerning drug injection practices (types of drugs, frequency of use, sharing experience) and characteristics of sexual behavior with primary and casual partners. Given the relatively low level of education among IDUs in China, we used a paperbased survey administered by an interviewer. Social desirability is a potential bias, but real-time logic was performed by the interviewer for consistency. Quality control in our study included the use of Study Specific Procedures and Standard Operating Procedures for interviewing and for training of staff, a private counseling room, and an ID number for the data form. Participants were instructed to return within 14 days for their test results. At the return visit, after HIV results were given, the HIV negative subjects were asked to give consent and were then enrolled into the cohort. HIV positive subjects were counseled and referred to physicians and psychologists working at the study site.
The design of the prospective HIV incidence cohort study required follow-up study visits which were scheduled at 6 and 12 months for each enrolled participant. The 6-month and 12-month follow-up visits served the purpose of collecting primary and secondary study endpoint data. The participants were required to attend these follow-up visits within a 45-day window period (15 days prior and 30 days after scheduled date). At each time point, participants completed a followup HIV risk assessment, received HIV pre-test and risk reduction counseling, underwent phlebotomy for HIV antibody testing, and received their HIV test results and post-test counseling (interim HIV counseling and testing could also have been performed, at participant request, between scheduled follow-up visits). During follow-up study visits, the same procedure for HIV testing was administered including confirmatory tests. The post-test visits were scheduled for a time during a period of 7-14 days after the corresponding follow-up visit. Subjects were paid 100 yuan (US $12.50) for each study visit to cover transportation costs and their time which could take up to a few hours per visit.
Participants who tested HIV positive during a follow-up visit were counseled, referred to available medical and psychosocial services, and referred to other available research studies. Participants who tested HIV negative were retained for follow-up over the next period of the study.
Study staff made 'locator contacts' with study participants at months 3 and 9. The locator contacts served the purpose of enhancing retention by providing a mechanism to confirm or update the participant's locator information (e.g., address, telephone number, name and address of family members), confirming or re-scheduling the participant's next follow-up visit, and reinforcing instructions for the participant to contact the study site to update locator information and/or, if needed, request HIV counseling and/ or testing between scheduled visits. In addition, any difficulties experienced in contacting participants at these time points served to trigger timely mobilization of outreach efforts to ensure that participants were located in time for their next scheduled follow-up visit. The contacts were conducted in person at the study site, via telephone, or via street/home outreach.
Statistical analysis
A sample size of 500 was set in order to achieve a half-width of about 2.5% for the 95% confidence interval for the HIV incidence (based on a 12-month retention rate of 90% and a true rate of 8% HIV seroincidence). Case report forms were faxed to the HPTN statistical and data management center (Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, USA) where the data were entered into the study database. All analyses were performed using SAS software (SAS version 8.2). Data on the method of recruitment were added to the database at a later date. Descriptive statistics on sociodemographic and behavioral characteristics of screened participants were computed. The HIV incidence density rate was calculated based on Poisson distribution, with person time of follow-up as the denominator. A proportional hazards model analysis was performed on the discrete time scale of semi-annual visits to identify the baseline predictors (sociodemographics, drug use, and sexual risk behaviors) of HIV incidence. A logistic regression was used to investigate the contribution of the baseline factors to the study retention rate.
Results
The recruitment, screening, and enrollment of high-risk IDUs occurred during a 6-month period beginning in July 2002 and ending in December 2002. More than 781 IDUs were prescreened for eligibility and interest, and 228/781 (29%) tested positive for HIV-1 antibody. A total of 508 eligible high-risk IDUs gave consent for this study. The ages of the participants ranged from 18 to 59 years, with a median of 29.3 years. The gender distribution was 87% male and 13% female. The majority of the participants were of either Uighur (46%) or Han (41%) ethnicity. Fifty-eight percent were single, and most had no college education (92%). Forty-nine percent were unemployed and 59% lived with parents. All (100%) had injected drugs in the month prior to baseline and reported having used heroin in the 3 months prior to baseline. There were no men who reported having had sex with men.
Participants were considered retained at the 12-month visit if they completed the 12-month follow-up visit or if they had seroconverted prior to the 12-month visit. Under this definition, the overall retention rate was 93% (472/508) for the 12-month visit. There were 66 (13%) participants who did not complete the 6-month visit and 36 (7%) participants did not complete the 12-month visit within the 45-day window period. Univariate logistic regression analysis did not identify any baseline predictors (sociodemographics, drug use, and sexual risk behaviors) for retention. Of the 36 participants lost to follow-up, 16 were unable to be contacted, eight died, seven missed their scheduled appointment, three were incarcerated, and two refused to further participate.
During the 12-month follow-up period, 42 HIV antibody seroconversions were observed to have occurred within 475 person-years of risk with 18/42 seroconverting by the 6month visit. The observed HIV incidence rate was 8.8 per 100 person-years (95% CI 6.3-12.0%). Univariate proportional hazard model analyses were performed on a discrete time scale of semi-annual visits to identify the baseline predictors (sociodemographics, drug use, and sexual risk behaviors). Marital status (single vs. married, RR = 2.64, 95% CI 1.08-6.42) was the only factor that was significantly associated with HIV incidence (See Table 1 ). All reported having used heroin, 49 reported having used tranquilizers, and 83 reported having used other drugs. Among those who seroconverted to HIV positive, five reported having used tranquilizers and six reported having used other drugs. The risk behavior category of being a male who sold sex (RR = 2.12, 95% CI 0.91-4.51) was marginally significantly associated with HIV incidence. No baseline variable was predictive of study retention.
Discussion
This study found that the HIV seroincidence rate during a 12-month follow-up among high-risk IDUs in Xinjiang was 8.8 per 100 person-years (95% CI 6.3-12.0%). Only marital status (being single) was a predictor for HIV seroconversion. Previous smaller studies have reported HIV seroincidence rates among other IDU populations in China. A study conducted in three counties of Yunnan Province during 1992-1994 found seroconversion rates from 0 to 25 per 100 person-years. 10 Another study reported an HIV incidence of 2.38 per 100 person-years among drug users during the first follow-up period (February 1998-January 1999) and 6.86 per 100 person-years during the second follow-up period (January-September 1999) in Pingxiang County of Guangxi Province. 11 A recent 12-month follow-up study in Xichang County of Sichuan province found an HIV incidence of 3.17 per 100 person-years (95% CI 0.98-5.37). 12 The study from Sichuan and our results from Xinjiang demonstrate that HIV is spreading rapidly among IDUs in geographic areas other than Yunnan and Guangxi, the typical epicenters of the HIV/AIDS epidemic in China. During the period for the above studies, drug treatment and needle and syringe exchange programs were not available to most IDUs. Intervention programs, including expanded treatment for drug abuse and harm-reduction strategies, should be implemented in IDU populations to prevent the spread of HIV infection.
The overall retention rate in this study was 93% for the 12-month visit. This is the first study in China to evaluate the retention rate in a prospective cohort study of injecting drug users. The retention methods used in the study were designed borrowing experiences from other international studies. 13, 14 Maintaining high retention rates is generally believed to be more difficult when working with IDU individuals in prospective cohort studies. Some studies have reported that approximately 25% of the participants were lost to follow-up. 15, 16 Our results suggest that a welldesigned and thoroughly executed retention plan is key to achieving high retention rates even when working with a high-risk IDU population. No baseline participant characteristics were found to significantly affect retention in this study. Several studies have also found that HIV high-risk behaviors are not associated with cohort retention. [13] [14] [15] 17 Limitations of this study include a possible selection and recall bias. Because this study was restricted to high-risk IDUs with the inclusion criteria, these results may not be representative of the general IDU population in the region and should be used with caution when applied to IDUs in other regions. IDUs who injected drugs and shared injection equipment less frequently than required by our inclusion criteria were not included in this study. It is possible that if these IDUs were included in the study, characteristics of drug injection behavior (such as the frequency of injection and the frequency of sharing equipment) might be found to be statistically associated with HIV seroconversion. Underreporting of risk behaviors in drug use and sexual activities by study participants is possible, which could have limited the detection of a significant association between behavioral risk variables and HIV incidence. In addition, since the time this study was conducted, several programs for harm reduction such as a needle exchange program, a methadone treatment program, and a peer education and AIDS CARE program have been initiated in Urumqi so the HIV incidence rates may currently be different.
Our data strongly demonstrate that HIV is spreading rapidly among high-risk IDUs in Xinjiang, China. The high seroincidence and retention rates in this population offer the opportunity to conduct randomized controlled trials for testing the efficacy of harm reduction and HIV prevention interventions.
